TRICHELLE FEHELEY: Open Payments
NPI 1518275023 · ENDWELL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 18 payments from 8 companies in 2025. Trend: 2023 $1,071 · 2024 $448 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $154 |
| ABBVIE INC. | 3 | $62 |
| Lilly USA, LLC | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Abbott Laboratories | 1 | $15 |
Products named: Ozempic, Rybelsus, QULIPTA, UBRELVY, JARDIANCE, INGREZZA, VOQUEZNA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
